List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 17 studies with search of: Open Studies | "Carcinoma, Small Cell"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Study of Arsenic Trioxide in Small Cell Lung Cancer
Conditions: Lung Cancer;   Cancer of Lung;   Pulmonary Cancer;   Pulmonary Neoplasms;   Carcinoma, Small Cell
Intervention: Drug: Arsenic Trioxide
2 Recruiting Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient
Condition: Carcinoma, Small Cell
Interventions: Drug: Belotecan/Cisplatin;   Drug: Etoposide/Cisplatin
3 Recruiting Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum
Conditions: Carcinoma, Small Cell;   Carcinoma, Non-small-cell Lung;   Esophageal Neoplasms;   Mesothelioma
Interventions: Drug: Depsipeptide;   Drug: Flavopiridol (alvocidib)
4 Recruiting N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy
Conditions: Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small Cell Lung;   Mesothelioma
Interventions: Drug: N-Acetylcysteine;   Drug: Placebo
5 Recruiting Metabolomic Analysis of Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung;   Carcinoma, Small Cell Lung
Intervention: Other: 13-C-glucose
6 Recruiting Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies
Conditions: Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small Cell Lung;   Carcinoma, Thymic
Interventions: Drug: AZD;   Drug: MK-2206;   Drug: Lapatinib;   Drug: Erlotinib;   Drug: Sunitinib;   Procedure: Molecular Profiling
7 Recruiting Study of ACE-011 to Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer
Conditions: Anemia;   Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small-Cell Lung;   Bladder Cancer;   Cancer of Head and Neck;   Uterine Cervical Cancer
Interventions: Drug: ACE-011 - 15 mg;   Drug: ACE-011 - 30 mg;   Drug: ACE-011 - 45 mg
8 Recruiting Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium
Condition: Bladder Cancer
Interventions: Radiation: PCI;   Other: Brain X-ray
9 Unknown † Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Gemcitabine and Docetaxel
10 Recruiting Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
Condition: Cervical Cancer
Interventions: Biological: cetuximab;   Drug: cisplatin;   Radiation: brachytherapy;   Radiation: radiation therapy
11 Recruiting Collecting Tumor Samples From Patients With Gynecological Tumors
Condition: Cancer
Intervention: Other: biologic sample preservation procedure
12 Recruiting Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer
Condition: Cervical Cancer
Interventions: Biological: filgrastim;   Biological: pegfilgrastim;   Drug: topotecan hydrochloride;   Drug: veliparib;   Other: laboratory biomarker analysis
13 Recruiting Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical Cancer
Condition: Cervical Cancer
Interventions: Biological: panitumumab;   Drug: cisplatin;   Radiation: brachytherapy;   Radiation: external beam radiation therapy
14 Recruiting Brivanib in Treating Patients With Persistent or Recurrent Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: brivanib alaninate;   Other: laboratory biomarker analysis
15 Recruiting Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
Conditions: Cervical Cancer;   Endometrial Cancer
Interventions: Drug: ferumoxtran-10;   Procedure: diagnostic lymphadenectomy;   Procedure: lymph node biopsy;   Procedure: lymphadenectomy;   Procedure: magnetic resonance imaging;   Procedure: positron emission tomography/computed tomography;   Radiation: fludeoxyglucose F 18
16 Recruiting Glycoprotein and Glycan in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes
Condition: Cervical Cancer
Interventions: Genetic: microarray analysis;   Genetic: mutation analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: lymphadenectomy
17 Recruiting Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer
Condition: Cervical Cancer
Interventions: Biological: live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001;   Other: laboratory biomarker analysis

† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services